Cellectar Biosciences Inc (CLRB)
3.11
-0.08
(-2.51%)
USD |
NASDAQ |
Apr 23, 16:00
3.09
-0.02
(-0.64%)
After-Hours: 20:00
Cellectar Biosciences Market Cap: 100.33M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 100.33M |
| April 22, 2024 | 102.91M |
| April 19, 2024 | 97.75M |
| April 18, 2024 | 98.07M |
| April 17, 2024 | 103.56M |
| April 16, 2024 | 106.78M |
| April 15, 2024 | 107.10M |
| April 12, 2024 | 113.23M |
| April 11, 2024 | 119.69M |
| April 10, 2024 | 112.59M |
| April 09, 2024 | 120.33M |
| April 08, 2024 | 122.91M |
| April 05, 2024 | 121.30M |
| April 04, 2024 | 120.01M |
| April 03, 2024 | 128.40M |
| April 02, 2024 | 128.72M |
| April 01, 2024 | 126.46M |
| March 28, 2024 | 128.40M |
| March 27, 2024 | 117.27M |
| March 26, 2024 | 124.20M |
| March 25, 2024 | 124.85M |
| March 22, 2024 | 130.66M |
| March 21, 2024 | 124.85M |
| March 20, 2024 | 77.38M |
| March 19, 2024 | 78.41M |
| Date | Value |
|---|---|
| March 18, 2024 | 69.49M |
| March 15, 2024 | 72.19M |
| March 14, 2024 | 70.12M |
| March 13, 2024 | 73.43M |
| March 12, 2024 | 75.30M |
| March 11, 2024 | 78.21M |
| March 08, 2024 | 82.98M |
| March 07, 2024 | 84.43M |
| March 06, 2024 | 82.98M |
| March 05, 2024 | 84.01M |
| March 04, 2024 | 87.96M |
| March 01, 2024 | 87.13M |
| February 29, 2024 | 81.32M |
| February 28, 2024 | 81.73M |
| February 27, 2024 | 80.49M |
| February 26, 2024 | 72.40M |
| February 23, 2024 | 69.29M |
| February 22, 2024 | 69.49M |
| February 21, 2024 | 67.94M |
| February 20, 2024 | 68.25M |
| February 16, 2024 | 71.46M |
| February 15, 2024 | 74.47M |
| February 14, 2024 | 72.60M |
| February 13, 2024 | 70.32M |
| February 12, 2024 | 72.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.678M
Minimum
Jun 03 2020
130.66M
Maximum
Mar 22 2024
37.07M
Average
27.56M
Median
Sep 20 2022
Market Cap Benchmarks
| Perspective Therapeutics Inc | 997.76M |
| Eli Lilly and Co | 708.98B |
| Actinium Pharmaceuticals Inc | 204.60M |
| Bristol-Myers Squibb Co | 99.07B |
| Altimmune Inc | 536.68M |
Market Cap Related Metrics
| Price | 3.11 |
| Earnings Yield | -99.68% |